Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia

Journal of Clinical Oncology

Volumn 28, Issue 22, 2010, Pages 3591-3596

  Boughey, Judy C ^a   Hartmann, Lynn C ^a   Anderson, Stephanie S ^a   Degnim, Amy C ^a   Vierkant, Robert A ^a   Reynolds, Carol A ^a   Frost, Marlene H ^a   Pankratz, V Shane ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST HYPERPLASIA; CANCER GROWTH; CANCER INVASION; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MODEL; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PATHOLOGIST; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; TYRER CUZICK MODEL; AGED; BREAST; BREAST TUMOR; EVALUATION; FAMILY HEALTH; HYPERPLASIA; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; STATISTICAL MODEL;

AGED; BREAST; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 77955916897     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.28.0784     Document Type: Article

References (27)

1. Hartmann LC, Sellers TA, Frost MH, et al: Benign breast disease and the risk of breast cancer. N Engl J Med 353:229-237, 2005 (Pubitemid 41058322)
2. Dupont WD, Parl FF, Hartmann WH, et al: Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258-1265, 1993 (Pubitemid 23054916)
3. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
4. Tyrer J, Duffy SW, Cuzick J: A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23:1111-1130, 2004 (Pubitemid 38477070)
5. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer 73:643-651, 1994 (Pubitemid 24046606)
6. Tice JA, Cummings SR, Smith-Bindman R, et al: Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model. Ann Intern Med 148:337-347, 2008 (Pubitemid 351665464)
7. Antoniou AC, Pharoah PD, McMullan G, et al: A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86:76-83, 2002 (Pubitemid 34146344)
8. Chen J, Pee D, Ayyagari R, et al: Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 98:1215-1226, 2006 (Pubitemid 44390992)
9. Pike MC, Krailo MD, Henderson BE, et al: 'Hormonal' risk factors, 'breast tissue age' and the ageincidence of breast cancer. Nature 303:767-770, 1983
10. Barlow WE, White E, Ballard-Barbash R, et al: Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 98:1204-1214, 2006 (Pubitemid 44390991)
11. Elmore JG, Fletcher SW: The risk of cancer risk prediction: "What is my risk of getting breast cancer?" J Natl Cancer Inst 98:1673-1675, 2006
12. Pankratz VS, Hartmann LC, Degnim AC, et al: Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 26:5374-5379, 2008
13. Amir E, Freedman O: Underestimation of risk by Gail model extends beyond women with atypical hyperplasia. J Clin Oncol 27:1526, 2009
14. Amir E, Evans DG, Shenton A, et al: Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807-814, 2003 (Pubitemid 37485490)
15. Degnim AC, Visscher DW, Berman HK, et al: Stratification of breast cancer risk in women with atypia: A Mayo cohort study. J Clin Oncol 25:2671-2677, 2007 (Pubitemid 47123172)
16. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985 (Pubitemid 15192861)
17. Page DL, Dupont WD, Rogers LW, et al: Atypical hyperplastic lesions of the female breast: A long-term follow-up study. Cancer 55:2698-2708, 1985 (Pubitemid 15092160)
18. Carter CL, Corle DK, Micozzi MS, et al: A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467-477, 1988
19. London SJ, Connolly JL, Schnitt SJ, et al: A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941-944, 1992
20. US Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151:716-726, 2009
21. Collins LC, Baer HJ, Tamimi RM, et al: The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: Results from the Nurses' Health Study. Cancer 107:1240-1247, 2006 (Pubitemid 44452772)
22. Vachon CM, van Gils CH, Sellers TA, et al: Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 9:217, 2007
23. Tice JA, Cummings SR, Ziv E, et al: Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94:115-122, 2005 (Pubitemid 41547108)
24. Wacholder S, Hartge P, Prentice R, et al: Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362:986-993, 2010
25. Visscher DW, Pankratz VS, Santisteban M, et al: Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 100:421-427, 2008 (Pubitemid 351480513)
26. Milanese TR, Hartmann LC, Sellers TA, et al: Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600-1607, 2006 (Pubitemid 44811643)
27. Santisteban M, Reynolds C, Barr Fritcher EG, et al: Ki67: A time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat 121:431-437, 2010